First Melanoma Patient About to Complete Course of Russian Personalized Cancer Vaccine
/ Go to the mediabankA medic fills a syringe with a vaccine 
/ Go to the mediabank
The patient is a 60-year-old resident of Russia’s Kursk region who received the first dose of the «Neoonkovak» vaccine in April.The man with melanoma that had spread to lymph nodes despite prior surgeries will receive the final dose of the vaccine in early September, Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, tells Sputnik.Russia’s Ministry of Health authorized clinical use of the mRNA oncovaccine in December.Production is handled by the National Medical Research Radiological Center.The cancer vaccine is created individually for each patient based on the molecular and genetic characteristics of their tumor.Twenty patients will receive Russia’s first skin cancer vaccine by the end of 2026, Alexander Gintsburg confirmed in July.
RussiaRussian Scientists to Deliver Melanoma Vaccines for 10 Patients Within 3 Months30 July, 07:52 GMT
